Drimva

Xaira Therapeutics

Vice President, Business Development and Alliance Management

$250K–$325K

South San Francisco, California, United States · Director · Full-time · Posted Aug 6, 2026

Experience
Significant experience required; no number of years specified.
Education
Advanced scientific or technical degree, MBA, JD, or equivalent experience is valued but not required.

About the job

Leads the origination, negotiation, and execution of strategic AI platform, technology, research, and multi-program partnerships, then supports their transition into alliance management.

What you'll do

  • Develop partnering strategy and originate high-value opportunities with pharmaceutical, biotechnology, technology, and other strategic organizations.
  • Lead complex transactions from initial engagement through diligence, negotiation, approval, and execution, including deal structuring and valuation.
  • Establish alliance governance and partner relationships, monitor obligations and outcomes, and identify risks and opportunities to expand collaborations.

What they ask for

  • Significant experience in business development, corporate development, licensing, strategic partnerships, or a related role in biotechnology, pharmaceuticals, TechBio, or a relevant technology organization.
  • Demonstrated experience leading and closing large, complex strategic transactions and originating and executing sell-side business development opportunities.
  • Demonstrated experience managing strategic alliances through governance, delivery, and expansion.
  • Ability to understand complex scientific and technical capabilities, including AI-enabled technologies, and translate them into strategic and commercial value.

Nice to have

  • Experience with platform, technology, AI, research collaboration, multi-program, or discovery-stage partnerships.
  • Advanced scientific or technical degree, MBA, JD, or equivalent experience is valued but not required.

Pay

$250,000 - $325,000 annually (base salary)

AI focus

Leads partnerships involving AI platforms, technologies, research, and drug discovery and development; positions AI capabilities commercially and supports alliance governance for AI-enabled collaborations.

Model-written summary · the original posting is authoritative

First seen Oct 27, 2026 · Last verified Nov 6, 2026 (UTC)